Significance of IASLC/ATS/ERS classification for early-stage lung adenocarcinoma patients in predicting benefit from adjuvant chemotherapy Journal Article

   

Authors:	Takahashi, Y.; Eguchi, T.; Bains, S.; Adusumilli, P. S.
Article Title:	Significance of IASLC/ATS/ERS classification for early-stage lung adenocarcinoma patients in predicting benefit from adjuvant chemotherapy
Keywords:	cancer survival; overall survival; histopathology; cancer recurrence; solid tumor; cancer adjuvant therapy; cancer patient; disease free survival; cancer staging; antineoplastic agent; dna repair; apoptosis; beta tubulin; editorial; excision repair cross complementing protein 1; prediction; risk factor; cancer mortality; lung adenocarcinoma; medical society; cancer classification; papillary carcinoma; navelbine; thymidylate synthase; acinar cell carcinoma; lobectomy; epidermal growth factor receptor kinase inhibitor; non small cell lung cancer; minimally invasive procedure; cancer prognosis; human; lepidic carcinoma; micropapillary cancer
Journal Title:	Annals of Translational Medicine
Volume:	4
Issue:	4
ISSN:	2305-5839
Publisher:	AME Publishing Company
Date Published:	2016-02-01
Start Page:	66
Language:	English
DOI:	10.3978/j.issn.2305-5839.2015.10.40
PROVIDER:	scopus
PMCID:	PMC4779772
PUBMED:	27004213
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85006207160&doi=10.3978%2fj.issn.2305-5839.2015.10.40&partnerID=40&md5=400d348b27f0dedd9093269667931393
Notes:	Editorial -- Export Date: 2 August 2016 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/95286